Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jacalyn Rosenblatt

Vaccine Therapy in Hematologic Malignancies

Blood

English

A Phase 1/2 Study of Evofosfamide, a Hypoxia-Activated Prodrug With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Myeloid-Derived Suppressor Cells as Effectors of Immune Suppression in Cancer

International Journal of Cancer

Cancer Research

Oncology

2016

English

Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development

English

The Medical Research Council Myeloma IX Trial: The Impact on Treatment Paradigms*

European Journal of Haematology

Medicine

Hematology

2011

English

Fusions of Dendritic Cells With Breast Carcinoma Stimulate the Expansion of Regulatory T Cells While Concomitant Exposure to IL-12, CpG Oligodeoxynucleotides, and Anti-Cd3/Cd28 Promotes the Expansion of Activated Tumor Reactive Cells

Journal of Immunology

Allergy

Immunology

2008

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jacalyn Rosenblatt

Vaccine Therapy in Hematologic Malignancies

A Phase 1/2 Study of Evofosfamide, a Hypoxia-Activated Prodrug With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma

Myeloid-Derived Suppressor Cells as Effectors of Immune Suppression in Cancer

Dendritic Cell Therapies for Hematologic Malignancies

The Medical Research Council Myeloma IX Trial: The Impact on Treatment Paradigms*

Fusions of Dendritic Cells With Breast Carcinoma Stimulate the Expansion of Regulatory T Cells While Concomitant Exposure to IL-12, CpG Oligodeoxynucleotides, and Anti-Cd3/Cd28 Promotes the Expansion of Activated Tumor Reactive Cells